Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.
The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.
Anterix Inc. director Mahvash Yazdi reported selling 7,000 shares of Common Stock at $80.00 per share in an open-market transaction. After this sale, she directly holds 19,407 shares. She also indirectly holds 750 shares through a 401(k) and 250 shares through the Yazdi Family Trust, where she serves as trustee and disclaims beneficial ownership beyond her pecuniary interest.
The filing is a Form 144 notice reporting proposed sales of Common stock by an issuer-affiliated account and related option exercise activity. The entry list shows multiple restricted stock entries and a Stock Option Exercise on 06/17/2026 with a quantity of 1,226 shares; other listed quantities include 554, 459, 541, 905 and 606 shares tied to various grant or vesting dates.
The header also includes numeric fields shown as 341134.50 and 18732889 alongside a broker address and the exchange NASDAQ; the document lists the broker as Morgan Stanley Smith Barney LLC. This filing reports planned dispositions and related issuer-side exercises/vesting; timing and full proceeds treatment are the items shown in the listed rows.
ATEX submitted a Form 144 notice disclosing intended sales of Common Stock. The filing lists a stock option exercise line for 13,711 shares dated 06/15/2026 and two restricted stock entries of 1,250 shares (dated 05/17/2026) and 2,750 shares (dated 05/22/2026). The entries identify Morgan Stanley Smith Barney LLC as the broker and NASDAQ as the market.
Anterix Inc. reported a strong turnaround for fiscal 2026, posting net income of $90.6 million for the year ended March 31, 2026, compared with a prior-year loss. Full-year spectrum revenue was $6.5 million, while results were heavily supported by gains on spectrum-related intangible assets.
The company recorded a $105.4 million gain on exchange of intangible assets and a $34.8 million gain on sale of intangible assets for the year. At March 31, 2026, Anterix held $98.5 million in cash and cash equivalents, no debt, and total assets of $465.2 million.
Deferred revenue reached $161.2 million combined current and noncurrent, reflecting contracted future performance obligations. Anterix expects contracted customer cash proceeds of $25.3 million in fiscal 2027 and $23.4 million thereafter, and it has $226.7 million remaining under its share repurchase program.
Anterix Inc. Chief Legal Officer & Corporate Secretary Gena L. Ashe reported a routine tax-related share withholding. On the transaction date, 2,501 shares of common stock were withheld by Anterix to cover withholding obligations tied to a partial vesting and settlement of restricted stock units, at an implied value of $60.00 per share. Following this non-market transaction, Ashe directly holds 13,531 shares of Anterix common stock.
Anterix Inc. reported that President and CEO Scott A. Lang received new equity awards. He was granted 18,210 shares of Common Stock as restricted stock units and now directly holds 26,470 common shares after this award.
Lang also received stock options for 72,839 shares of Common Stock at an exercise price of $60.90 per share, expiring on May 20, 2036. Both the RSUs and the options vest over three years, with one-third vesting on May 20, 2027 and the remaining portions vesting in equal quarterly installments through May 20, 2029.
Anterix Inc. reported that Chief Legal Officer & Corporate Secretary Gena L. Ashe received equity awards as compensation. She was granted 3,694 restricted stock units, increasing her direct common stock holdings to 16,032 shares. She also received options for 17,453 shares at an exercise price of $60.90 per share, expiring on May 20, 2036. Both the RSUs and options vest over three years, with one-third vesting on May 20, 2027 and the remainder vesting in equal quarterly installments through May 20, 2029.
Anterix Inc. reported that Chief Reg & Comm Officer Christopher Guttman-McCabe received equity awards as part of his compensation. He was granted 4,926 restricted stock units, each representing one share of common stock, vesting over three years starting on May 20, 2027.
He also received options on 23,271 shares of common stock at an exercise price of $60.90, vesting on the same three-year schedule and expiring on May 20, 2036. Following these awards, he directly holds 46,392 shares of common stock.